About USIFX
Victory International Fund is a mutual fund focused on achieving capital appreciation by investing primarily in equity securities of companies based outside the United States. The fund seeks to provide investors with international diversification, allocating at least 80% of its assets to foreign companies, including those in both developed and emerging markets. It follows a "large blend" investment style, targeting a mix of growth and value stocks across a broad spectrum of sectors such as healthcare, technology, energy, financial services, and consumer goods. Notable holdings include globally recognized firms such as Novartis, Novo Nordisk, SAP, Shell, and Toyota Motor Corporation.
With a substantial portfolio—typically comprising over 500 holdings—the fund emphasizes a "best ideas" approach, identifying companies considered to have strong future prospects. Victory International Fund is managed by a team of multiple investment managers and is designed to complement domestic portfolios by offering exposure to global markets. Its performance is benchmarked against the MSCI EAFE Index, reflecting its focus on large international equities. The fund also provides income through semi-annual dividend distributions, supporting its role as a vehicle for both growth potential and periodic income in the international mutual fund space.
Fund Family Victory Capital
Category Foreign Large Blend
Stock Exchange NASDAQ
Ticker Symbol USIFX
Share Class Victory International Fund Shares
Index MSCI EAFE NR USD
USIFX had a total return of 19.43% in the past year, including dividends. Since the fund's
inception, the average annual return has been 7.34%.
